GlaxoSmithKline PLC (UK) Analysis
| GSK Stock | 1,340 3.50 0.26% |
GlaxoSmithKline PLC is overvalued with Real Value of 1179.64 and Hype Value of 1343.47. The main objective of GlaxoSmithKline PLC stock analysis is to determine its intrinsic value, which is an estimate of what GlaxoSmithKline PLC is worth, separate from its market price. There are two main types of GlaxoSmithKline PLC's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect GlaxoSmithKline PLC's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of GlaxoSmithKline PLC's stock to identify patterns and trends that may indicate its future price movements.
The GlaxoSmithKline PLC stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and GlaxoSmithKline PLC's ongoing operational relationships across important fundamental and technical indicators.
GlaxoSmithKline |
GlaxoSmithKline Stock Analysis Notes
About 45.0% of the company shares are owned by institutional investors. The book value of GlaxoSmithKline PLC was currently reported as 3.43. The company has Price/Earnings To Growth (PEG) ratio of 0.76. GlaxoSmithKline PLC last dividend was issued on the 14th of November 2024. The entity had 4:5 split on the 19th of July 2022. To learn more about GlaxoSmithKline PLC call Emma Walmsley at 44 20 8047 5000 or check out https://www.gsk.com.GlaxoSmithKline PLC Quarterly Total Revenue |
|
GlaxoSmithKline PLC Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. GlaxoSmithKline PLC's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding GlaxoSmithKline PLC or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| GlaxoSmithKline PLC generated a negative expected return over the last 90 days | |
| On 10th of October 2024 GlaxoSmithKline PLC paid 0.15 per share dividend to its current shareholders | |
| Latest headline from news.google.com: GSK Drug for Rare Disease-Related Itch Meets Goal in Phase III Study - Zacks Investment Research |
GlaxoSmithKline Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 54.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GlaxoSmithKline PLC's market, we take the total number of its shares issued and multiply it by GlaxoSmithKline PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.GlaxoSmithKline Profitablity
GlaxoSmithKline PLC's profitability indicators refer to fundamental financial ratios that showcase GlaxoSmithKline PLC's ability to generate income relative to its revenue or operating costs. If, let's say, GlaxoSmithKline PLC is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, GlaxoSmithKline PLC's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of GlaxoSmithKline PLC's profitability requires more research than a typical breakdown of GlaxoSmithKline PLC's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08. Management Efficiency
GlaxoSmithKline PLC has return on total asset (ROA) of 0.0724 % which means that it generated a profit of $0.0724 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2185 %, meaning that it generated $0.2185 on every $100 dollars invested by stockholders. GlaxoSmithKline PLC's management efficiency ratios could be used to measure how well GlaxoSmithKline PLC manages its routine affairs as well as how well it operates its assets and liabilities. At present, GlaxoSmithKline PLC's Other Current Assets are projected to decrease significantly based on the last few years of reporting.The decision-making processes within GlaxoSmithKline PLC are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Dividend Yield 0.0446 | Operating Margin 0.0833 | Profit Margin 0.0802 | Forward Dividend Yield 0.0446 | Beta 0.33 |
Technical Drivers
As of the 29th of November, GlaxoSmithKline PLC retains the market risk adjusted performance of (1.14), and Risk Adjusted Performance of (0.18). GlaxoSmithKline PLC technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out GlaxoSmithKline PLC information ratio, potential upside, and the relationship between the standard deviation and maximum drawdown to decide if GlaxoSmithKline PLC is priced fairly, providing market reflects its last-minute price of 1340.5 per share.GlaxoSmithKline PLC Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. GlaxoSmithKline PLC middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for GlaxoSmithKline PLC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
GlaxoSmithKline PLC Outstanding Bonds
GlaxoSmithKline PLC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GlaxoSmithKline PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GlaxoSmithKline bonds can be classified according to their maturity, which is the date when GlaxoSmithKline PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
GlaxoSmithKline PLC Predictive Daily Indicators
GlaxoSmithKline PLC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GlaxoSmithKline PLC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 43405.77 | |||
| Daily Balance Of Power | (0.22) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1339.5 | |||
| Day Typical Price | 1339.83 | |||
| Price Action Indicator | (0.75) | |||
| Period Momentum Indicator | (3.50) | |||
| Relative Strength Index | 36.74 |
GlaxoSmithKline PLC Forecast Models
GlaxoSmithKline PLC's time-series forecasting models are one of many GlaxoSmithKline PLC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GlaxoSmithKline PLC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About GlaxoSmithKline Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how GlaxoSmithKline PLC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GlaxoSmithKline shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as GlaxoSmithKline PLC. By using and applying GlaxoSmithKline Stock analysis, traders can create a robust methodology for identifying GlaxoSmithKline entry and exit points for their positions.
GlaxoSmithKline PLC is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding GlaxoSmithKline PLC to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Complementary Tools for GlaxoSmithKline Stock analysis
When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |